Delirium common but poorly understood in older chemotherapy patients
Delirium appears to be relatively common among older cancer patients receiving chemotherapy, developing in around 10 percent of this population, a recent meta-analysis has found. However, due to gaps in the literature, potential risk factors and interventions remain unestablished.
